SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001072613-18-000451
Filing Date
2018-08-24
Accepted
2018-08-27 08:20:05
Documents
1
Group Members
GARY LEATTHELMUT SCHUHSLERHUBERT BIRNERLUC MARENGERERESHENTHA BEEBYSTEFAN FISCHERTVM LIFE SCIENCE VENTURES MANAGEMENT VI L.P.TVM LIFE SCIENCE VENTURES VI GMBH & CO. KGTVM LIFE SCIENCE VENTURES VII L.P.TVM LSV VII (GP) LTD.

Document Format Files

Seq Description Document Type Size
1 TVM LIFE SCIENCE VENTURES VI L.P. / ACER THERAPEUTICS INC. - SCHEDULE 13D/A(#1) tvm-acer_13d18244.htm SC 13D/A 362111
  Complete submission text file 0001072613-18-000451.txt   364246
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Subject) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81104 | Film No.: 181038144
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address PO BOX 309 UGLAND HOUSE CAYMAN ISLAND A1 00000
Business Address PO BOX 309 UGLAND HOUSE CAYMAN ISLAND A1 00000
TVM Life Science Ventures VI LP (Filed by) CIK: 0001318584 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A